Document is current

Article History

Received: 3 July 2022

Accepted: 18 January 2023

First Online: 7 February 2023

Declarations

:

: The study was conducted following the ethical principles of the Declaration of Helsinki and the local regulation, including privacy laws. The protocol of the BARI study was validated by a panel of clinical experts, classified by the Agency of Medicines and Medical Devices (AEMPS) as an observational study and approved by the Ethics Committee of Hospital Clinic de Barcelona (HCB/2020/1132). Informed consent to participate was waived by the same ethics committee that approved the study (Ethics Committee of Hospital Clinic de Barcelona).

: Not applicable.

: Drago G, López-Belmonte JL, Bricout H, and de Courville C are the employees of Sanofi and may hold shares and/or stock options in the company. Carmo M, Bizouard G are the employees of IQVIA. Gil-de-Miguel A and Díez-Domingo J have received fees from Sanofi. Martinón-Torres F received honoraria from GSK group of companies, Pfizer Inc, Sanofi, MSD, Seqirus, and Janssen for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work. Martinón-Torres F has also acted as the principal investigator in randomized controlled trials of the above-mentioned companies as well as Ablynx, Gilead, Regeneron, Roche, Abbott, Novavax, and MedImmune, with honoraria paid to his institution. Ortiz de Lejarazu R received honoraria from AstraZeneca, GSK, MSD, Roche, Sanofi, and Seqirus for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work. Ortiz de Lejarazu R has been the Director of the National Influenza Centre, Valladolid, Spain, until 2019, without any salary for that position and has participated in regular commitments of influenza and other respiratory virus surveillance. Pumarola T received honoraria from Roche, Sanofi, Seegene, and Seqirus for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work. Redondo Margüello E received honoraria from GSK group of companies, Pfizer Inc, Sanofi, and MSD, for taking part in advisory boards and expert meetings and for acting as a speaker in congresses outside the scope of the submitted work.